Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors	Ewing sarcoma, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, bone marrow disorder, connective tissue neoplasm, epithelial neoplasm, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, myomatous neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, non-Hodgkin lymphoma, osteosarcoma, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma	Recruiting	Phase 1	2025-10-16		NCT02508038

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Wisconsin, Madison	265

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Wisconsin Carbone Cancer Center	Madison	United States	14